Editas Medicine (NASDAQ:EDIT) reported its Q1 earnings results on Wednesday, May 4, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
Editas Medicine beat estimated earnings by 6.33%, reporting an EPS of $-0.74 versus an estimate of $-0.79.
Revenue was up $272.00 thousand from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.11 which was followed by a 6.56% increase in the share price the next day.
Here's a look at Editas Medicine's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.72 | -0.82 | -0.83 | -0.75 |
| EPS Actual | -0.61 | -0.57 | -0.81 | -0.86 |
| Revenue Estimate | 4.29M | 4.78M | 6.17M | 5.14M |
| Revenue Actual | 12.47M | 6.20M | 379.00K | 6.50M |
To track all earnings releases for Editas Medicine visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
